DMAC (STOCKS)
DiaMedica Therapeutics Inc. Common Stock
$6.300000
+0.310000 (+5.18%)
Prev close: $5.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rick John Pauls
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $338.38M
- Employees
- 28
- P/E (TTM)
- -8.58
- P/B (TTM)
- 5.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.66M |
| Operating Expenses | $34.40M |
| Research and Development | $24.61M |
| Other Operating Expenses | $9.78M |
| Operating Income/Loss | -$34.40M |
| Income/Loss From Continuing Operations After Tax | -$32.77M |
| Income/Loss From Continuing Operations Before Tax | -$32.74M |
| Income Tax Expense/Benefit | $28.00K |
| Income Tax Expense/Benefit, Current | $28.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$32.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$32.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$32.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.70 |
| Basic Average Shares | 46,980,777 |
| Assets | $61.37M |
| Current Assets | $60.63M |
| Cash | $59.90M |
| Other Current Assets | $729.00K |
| Noncurrent Assets | $742.00K |
| Fixed Assets | $145.00K |
| Other Non-current Assets | $597.00K |
| Liabilities | $5.26M |
| Current Liabilities | $5.13M |
| Accounts Payable | $1.48M |
| Wages | $1.38M |
| Other Current Liabilities | $2.28M |
| Noncurrent Liabilities | $128.00K |
| Equity | $56.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $56.11M |
| Liabilities And Equity | $61.37M |
| Net Cash Flow From Operating Activities | -$29.06M |
| Net Cash Flow From Operating Activities, Continuing | -$29.06M |
| Net Cash Flow From Investing Activities | -$2.19M |
| Net Cash Flow From Investing Activities, Continuing | -$2.19M |
| Net Cash Flow From Financing Activities | $43.88M |
| Net Cash Flow From Financing Activities, Continuing | $43.88M |
| Net Cash Flow | $12.62M |
| Net Cash Flow, Continuing | $12.62M |
| Comprehensive Income/Loss | -$32.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$32.74M |
| Other Comprehensive Income/Loss | -$32.74M |